TISSIUM™ Atraumatic Hernia Repair System (TAHRS)
DeviceThe TAHRS is intended for fixation of prosthetic material to soft tissue
NCT Number: NCT06042205
The purpose of this study is to capture preliminary clinical safety and performance on the TAHRS
This study is active but is not currently recruiting participants.
18 year–65 year
All sexes
Interventional
Not applicable
Ziekenhuis Oost-Limburg [ZOL], Genk, Limburg, Belgium
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Key Inclusion Criteria:
Key Exclusion Criteria:
The TAHRS is intended for fixation of prosthetic material to soft tissue
Time frame: through 12 months post-surgery
Cumulative incidence of complications (CIC) related to the TAHRS including:
Infection, Chronic pain, Recurrence of hernia, Impaired/delayed healing at the surgical site(s), Allergic reaction/hypersensitivity reaction,
Time frame: through 12 months post-surgery
Tissium
Industry
ALPHA: A Pilot Study to Evaluate the Initial Safety and Performance of the TISSIUM™ Atraumatic Hernia Repair System (TAHRS) for Laparoscopic Hernia Repair
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT06449378
HERNIA, VENTRAL, Hernia
Evanston, Illinois, United States
View Trial DetailsNCT07267494
Diastasis Recti, Hernia
Sacramento, California, United States
View Trial DetailsNCT07277946
Hernia, Pathological Conditions, Anatomical
Loma Linda, California, United States
View Trial DetailsNCT07628205
Hernia, Pathological Conditions, Anatomical
Legnano, Milano, Italy
View Trial Details